https://www.selleckchem.com/pr....oducts/ionomycin.htm
79. However, in patients with DBT, MR detected significantly more additional sites of malignancy in dense compared to non-dense breasts (p=0.017). There was no difference in false-positive MR exams (p=0.47 for DM versus DBT. For both DM and DBT cohorts, higher MR background parenchymal enhancement was associated with higher false-positive (p=0.04 but no significant difference in true-positive exams. Among patients with DBT imaging at cancer diagnosis, women with dense breasts appear to benefit more from preoperative MR than non-
Like
Comment
Share
